ATLANTA, GA – – (Globe Newswire – March 20, 2024) – – Holzer & Holzer, LLC is investigating whether Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) complied with federal securities laws. On March 20, 2024, Lifecore filed its Annual Report on Form 10-K for the fiscal year ended May 28, 2023, which contained restatements of certain previously issued financial statements that corrected “errors involving the calculation of capitalized interest, valuation of inventories, and certain other adjustments related to previously divested businesses.” Following this news, the Company’s stock price declined.

If you purchased Lifecore stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  cholzer@holzerlaw.com  or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at https://holzerlaw.com/case/lifecore/ discuss your legal rights.